From PPMD:
1. We want to acknowledge and thank the brave patients and families who participate in clinical trials, despite the absence of guaranteed benefit.
2. PPMD will continue to work closely with researchers, industry partners, and the entire Duchenne community to ensure that every effort is made to bring safe and effective treatments to those who need them.
It reminds me the following statements made by both Dr.Charmanine Gittleson & Professor Voit:
1. “This is a major milestone for Antisense Therapeutics and the DMD community”, said Dr Charmaine Gittleson, Antisense Board Chair. “I am excited that ATL1102 has again entered a clinical trial and we genuinely hope the study participants and future patients with DMD will benefit from this treatment.”
2. Professor Voit noted “I am very pleased that the ATL1102 Phase IIb clinical trial has commenced patient enrolment. There is high need for new therapeutic approaches for the treatment of DMD and this trial is an important step towards finding effective treatment options for DMD patients and providing hope for their families.”
Hopefully by the end of this year, Professor Voit will send us Christmas presents...
- Forums
- ASX - By Stock
- Ann: Phase IIb study of ATL1102 in DMD completes recruitment
From PPMD:1. We want to acknowledge and thank the brave patients...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
(20min delay)
|
|||||
Last
7.0¢ |
Change
-0.001(1.41%) |
Mkt cap ! $63.10M |
Open | High | Low | Value | Volume |
7.1¢ | 7.1¢ | 6.9¢ | $34.01K | 486.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 132919 | 6.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.3¢ | 78000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 80000 | 0.069 |
4 | 134427 | 0.068 |
3 | 224490 | 0.067 |
1 | 15000 | 0.066 |
4 | 32000 | 0.065 |
Price($) | Vol. | No. |
---|---|---|
0.073 | 78000 | 1 |
0.075 | 13371 | 1 |
0.078 | 75476 | 2 |
0.079 | 175123 | 2 |
0.080 | 287231 | 3 |
Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
Featured News
STX
Strike hands $48.5M contract to Clarke Energy to produce 20x 4.5MW gas engines for Sth Erregulla
AVH
Avita boosts skin restoration product portfolio with 'dermal matrix' – a kind of next-level gauze made of fake skin
PER (ASX) Chart |